<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81892">
  <stage>Registered</stage>
  <submitdate>5/03/2007</submitdate>
  <approvaldate>7/05/2007</approvaldate>
  <actrnumber>ACTRN12607000240448</actrnumber>
  <trial_identification>
    <studytitle>Liver and muscle triglyceride and muscle metabolic rate in overweight and type 2 diabetes</studytitle>
    <scientifictitle>Effect of aerobic exercise training on changes in muscle metabolic rate, liver and muscle triglyceride concentration in overweight adults and adults with type 2 diabetes</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Type 2 diabetes</healthcondition>
    <healthcondition>Overweight</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Four week progressive aerobic exercise training versus sedentary control.  Participants will undertake supervised cycle ergometer exercise 4 days per week.   Week 1: 30 min per day (as 2 x 15 min bouts at 50% VO2max); Week 2: 45 min per day (as 30 min + 15 min bouts at 50% VO2max); Week 3: 60 min per day (as 2 x 30 min at 60% VO2max); Week 4; 60 min per day (as 2 x 30 min or 60 min continuous at 65% VO2max).</interventions>
    <comparator>Volunteers recruited to the 'sedentary control' group will receive no treatment/intervention as they are healthy individuals.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Changes in muscle metabolic rate</outcome>
      <timepoint>At 4 weeks relative to baseline</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Changes in muscle and liver triglyceride concentration</outcome>
      <timepoint>At 4 weeks relative to baseline</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in peak aerobic capacity</outcome>
      <timepoint>Assessed by incremental exercise test after 4 weeks of training (versus baseline).</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Inclusion for overweight and type 2 diabetes groups: Body mass index (BMI)&gt;25 kg/m2 with or without type 2 diabetes.
Inclusion for lean non-diabetic group = BMI &lt; 25.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>BMI&gt;30, advanced cardiovascular disease, musculoskeletal ailment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/05/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Sydney</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Nestle</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Commercial sector/Industry</sponsortype>
      <sponsorname>Rayscan Imaging Liverpool</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>3 groups of individuals will be recruited for the research: a. lean healthy individuals b. overweight individuals with type 2 diabetes c. overweight (matched to b) non-diabetic individuals.  All groups will be assessed and compared for muscle and liver triglyceride concentration and muscle metabolic rate to address the hypothesis that overweight and/or type 2 diabetes is associated with low metabolic rate and elevated liver and muscle triglyceride content.  Individuals in groups b and c will then undertake 4 weeks of aerobic exercise training to determine if training influences these metabolic 'abnormalities'.  This will be determined by comparing these measures AFTER 4 training weeks with those determined PRE-TRAINING.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Sydney Human Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Nathan Johnson</name>
      <address>Faculty of Health Sciences
University of Sydney
East St
Lidcombe NSW 2141</address>
      <phone>+61 2 93519137</phone>
      <fax />
      <email>n.johnson@usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Nathan Johnson</name>
      <address>Faculty of Health Sciences
University of Sydney
East St
Lidcombe NSW 2141</address>
      <phone>+61 2 93519137</phone>
      <fax />
      <email>n.johnson@usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>